GSK and CureVac join forces to develop vaccines targeting new COVID-19 variants By: MarketWatch February 03, 2021 at 04:45 AM EST GSK and CureVac said their approach could potentially tackle multiple coronavirus strains in one vaccine shot Read More >> Related Stocks: Biontech Se ADR Curevac N.V. Gsk Plc ADR Microsoft Moderna Inc Pfizer
